Alp Bayrak

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Pulmonary Embolism

Structure Activity Relationship

Cardiovascular Disease

Top Venues

Journal of medicinal chemistry

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Alp Bayrak, Martyna Szpakowska, Valerie Dicenta, Manuel Counson, Alexander Rasch, Anne-Katrin Rohlfing, Andy Chevigné, Meinrad Gawaz, Stefan A Laufer, Thanigaimalai Pillaiyar
Novel Small-Molecule Atypical Chemokine Receptor 3 Agonists: Design, Synthesis, and Pharmacological Evaluation for Antiplatelet Therapy. Journal of medicinal chemistry 67 (16) (2024)
Alp Bayrak, Martyna Szpakowska, Valerie Dicenta, Manuel Counson, Alexander Rasch, Anne-Katrin Rohlfing, Andy Chevigné, Meinrad Gawaz, Stefan A Laufer, Thanigaimalai Pillaiyar
Novel Small-Molecule Atypical Chemokine Receptor 3 Agonists: Design, Synthesis, and Pharmacological Evaluation for Antiplatelet Therapy. Journal of medicinal chemistry (2024)
Alp Bayrak, Martyna Szpakowska, Valerie Dicenta, Manuel Counson, Alexander Rasch, Anne-Katrin Rohlfing, Andy Chevigné, Meinrad Gawaz, Stefan A Laufer, Thanigaimalai Pillaiyar
Novel Small-Molecule Atypical Chemokine Receptor 3 Agonists: Design, Synthesis, and Pharmacological Evaluation for Antiplatelet Therapy. Journal of medicinal chemistry 67 (16) (2024)
Alp Bayrak, Julien Hanson, Stefan A Laufer, Thanigaimalai Pillaiyar
Super-conserved receptors expressed in the brain: biology and medicinal chemistry efforts. Future medicinal chemistry 14 (12) (2022)
Alp Bayrak, Florian Mohr, Kyra Kolb, Martyna Szpakowska, Ekaterina Shevchenko, Valerie Dicenta, Anne-Katrin Rohlfing, Mark Kudolo, Tatu Pantsar, Marcel Günther, Agnieszka A Kaczor, Antti Poso, Andy Chevigné, Thanigaimalai Pillaiyar, Meinrad Gawaz, Stefan A Laufer
Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation. Journal of medicinal chemistry 65 (19) (2022)